Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
2.62
↑ 307% above average
Average (9y)
-1.27
Historical baseline
Range
High:12.68
Low:-26.77
CAGR
+1.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.62 | -10.3% |
| 2023 | 2.92 | +56.2% |
| 2022 | 1.87 | +182.4% |
| 2021 | -2.27 | +37.8% |
| 2020 | -3.65 | +43.3% |
| 2019 | -6.43 | +76.0% |
| 2018 | -26.77 | -311.2% |
| 2017 | 12.68 | +211.5% |
| 2016 | 4.07 | +76.7% |
| 2015 | 2.30 | - |